Metastases in normal-sized pelvic lymph nodes: Detection with diffusion-weighted MR imaging

Radiology

Volumn 273, Issue 1, 2014, Pages 125-135

  Thoeny, Harriet C ^a   Froehlich, Johannes M ^a   Triantafyllou, Maria ^a   Huesler, Juerg ^a   Bains, Lauren J ^a   Vermathen, Peter ^a   Fleischmann, Achim ^b   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; MAGNETITE NANOPARTICLE;

ADULT; AGED; BLADDER TUMOR; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC USE; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PELVIS; PROCEDURES; PROSPECTIVE STUDY; PROSTATE TUMOR; THREE DIMENSIONAL IMAGING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84908687732     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14132921     Document Type: Review

References (27)

1. Studer UE, Scherz S, Scheidegger J, et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 1990; 144 (2 Pt 1) : 243-245.
2. Bader P, Burkhard FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002; 168 (2) : 514-518; discussion 518.
3. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 2005; 23 (10) : 2358-2365.
4. Deserno WM, Harisinghani MG, Taupitz M, et al. Urinary bladder cancer: Preoper ative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 2004; 233 (2) : 449-456.
5. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348 (25) : 2491-2499.
6. Triantafyllou M, Studer UE, Birkhäuser FD, et al. Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer 2013; 49 (3) : 616-624.
7. Birkhäuser FD, Studer UE, Froehlich JM, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol 2013; 64 (6) : 953-960.
8. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168 (2) : 497-505.
9. Thoeny HC, Ross BD. Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging 2010; 32 (1) : 2-16.
10. Ginat DT, Mangla R, Yeaney G, Johnson M, Ekholm S. Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density. AJR Am J Roentgenol 2012; 198 (6) : W597-W601.
11. Thoeny HC, Forstner R, De Keyzer F. Genitourinary applications of diffusion-weighted MR imaging in the pelvis. Radiology 2012; 263 (2) : 326-342.
12. Giannarini G, Petralia G, Thoeny HC. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: A critical analysis of the literature. Eur Urol 2012; 61 (2) : 326-340.
13. Eiber M, Beer AJ, Holzapfel K, et al. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR imaging. Invest Radiol 2010; 45 (1) : 15-23.
14. Park SO, Kim JK, Kim KA, et al. Relative apparent diffusion coefficient: Determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer. J Magn Reson Imaging 2009; 29 (2) : 383-390.
15. Roy C, Bierry G, Matau A, Bazille G, Pasquali R. Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T. Eur Radiol 2010; 20 (8) : 1803-1811.
16. Nakai G, Matsuki M, Inada Y, et al. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr 2008; 32 (5) : 764-768.
17. Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009; 55 (4) : 761-769.
18. Froehlich JM, Triantafyllou M, Fleischmann A, Vermathen P, Thalmann GN, Thoeny HC. Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes? Contrast Media Mol Imaging 2012; 7 (3) : 346-355.
19. Roth B, Wissmeyer MP, Zehnder P, et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 2010; 57 (2) : 205-211.
20. Sobin L, Gospodarowicz M, Wittekind C. UICC, International Union Against Cancer, TNM classification of malignant tumours. 7th ed. West Sussex, England: Wiley-Blackwell, 2010.
21. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (1) : 159-174.
22. Rechichi G, Galimberti S, Oriani M, Perego P, Valsecchi MG, Sironi S. ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer. Eur Radiol 2013; 23 (1) : 65-74.
23. Papalia R, Simone G, Grasso R, et al. Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: Detection rate of pelvic lymph node metastases. BJU Int 2012; 109 (7) : 1031-1036.
24. Kim JK, Kim KA, Park BW, Kim N, Cho KS. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: Early experience. J Magn Reson Imaging 2008; 28 (3) : 714-719.
25. Choi EK, Kim JK, Choi HJ, et al. Node-bynode correlation between MR and PET/CT in patients with uterine cervical cancer: Diffusion-weighted imaging versus size-based criteria on T2WI. Eur Radiol 2009; 19 (8) : 2024-2032.
26. Budiharto T, Joniau S, Lerut E, et al. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases. Eur Urol 2011; 60 (1) : 125-130.
27. Maurer T, Souvatzoglou M, Kübler H, et al. Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 2012; 61 (5) : 1031-1038.